Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -180.40M | -170.37M | -156.16M | -138.74M | -51.24M |
| Total Depreciation and Amortization | 892.00K | 1.00M | 1.85M | 2.73M | 3.51M |
| Total Amortization of Deferred Charges | 999.00K | 985.00K | 972.00K | 958.00K | 1.03M |
| Total Other Non-Cash Items | 16.65M | 10.75M | 10.72M | 3.66M | 5.02M |
| Change in Net Operating Assets | -8.41M | -13.63M | -15.82M | -22.90M | 50.79M |
| Cash from Operations | -170.26M | -171.27M | -158.43M | -154.30M | 9.11M |
| Capital Expenditure | -53.00K | -79.00K | -79.00K | -79.00K | -26.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 175.96M | 156.44M | 136.50M | 92.73M | -10.56M |
| Cash from Investing | 175.90M | 156.36M | 136.42M | 92.65M | -10.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -9.68M |
| Issuance of Common Stock | 6.43M | 6.43M | 2.47M | 879.00K | 785.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 464.00K |
| Cash from Financing | 6.43M | 6.43M | 2.47M | 879.00K | -8.43M |
| Foreign Exchange rate Adjustments | -65.00K | 141.00K | 14.00K | 202.00K | 65.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.01M | -8.34M | -19.53M | -60.57M | -9.84M |